These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 9374418)

  • 1. Intracellular metabolism of 3'-azido-3'-deoxythymidine (AZT): a nuclear magnetic resonance study on T-lymphoblastoid cell lines with different resistance to AZT.
    Di Vito M; Bozzi A; Ferretti A; Cianfriglia M; Barca S; Signoretti C; Lenti L; d'Agostino F; Strom R; Podo F
    Biochem Pharmacol; 1997 Nov; 54(9):979-90. PubMed ID: 9374418
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxicity of 3'-azido-3'-deoxythymidine correlates with 3'-azidothymidine-5'-monophosphate (AZTMP) levels, whereas anti-human immunodeficiency virus (HIV) activity correlates with 3'-azidothymidine-5'-triphosphate (AZTTP) levels in cultured CEM T-lymphoblastoid cells.
    Törnevik Y; Ullman B; Balzarini J; Wahren B; Eriksson S
    Biochem Pharmacol; 1995 Mar; 49(6):829-37. PubMed ID: 7702641
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amino acid phosphoramidate monoesters of 3'-azido-3'-deoxythymidine: relationship between antiviral potency and intracellular metabolism.
    Chang S; Griesgraber GW; Southern PJ; Wagner CR
    J Med Chem; 2001 Jan; 44(2):223-31. PubMed ID: 11170632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monitoring the intracellular metabolism of nucleoside phosphoramidate pronucleotides by 31P NMR.
    Kim J; Drontle DP; Wagner CR
    Nucleosides Nucleotides Nucleic Acids; 2004; 23(1-2):483-93. PubMed ID: 15043168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Further study of the mechanism underlying the cellular resistance to AZT.
    Turriziani O; Antonelli G; Focher F; Bambacioni F; Dianzani F
    Biochem Biophys Res Commun; 1996 Nov; 228(3):797-801. PubMed ID: 8941356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular metabolism of CycloSaligenyl 3'-azido-2', 3'-dideoxythymidine monophosphate, a prodrug of 3'-azido-2', 3'-dideoxythymidine (zidovudine).
    Balzarini J; Naesens L; Aquaro S; Knispel T; Perno C; De Clercq E; Meier C
    Mol Pharmacol; 1999 Dec; 56(6):1354-61. PubMed ID: 10570065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AZT and AZT-monophosphate prodrugs incorporating HIV-protease substrate fragment: synthesis and evaluation as specific drug delivery systems.
    Liotard JF; Mehiri M; Di Giorgio A; Boggetto N; Reboud-Ravaux M; Aubertin AM; Condom R; Patino N
    Antivir Chem Chemother; 2006; 17(4):193-213. PubMed ID: 17066898
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of zidovudine (AZT) resistance in Jurkat T cells is associated with decreased expression of the thymidine kinase (TK) gene and hypermethylation of the 5' end of human TK gene.
    Wu S; Liu X; Solorzano MM; Kwock R; Avramis VI
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Jan; 8(1):1-9. PubMed ID: 8548339
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alteration of thymidine kinase activity in cells treated with an antiviral agent.
    Turriziani O; Antonelli G; Verri A; Tozzi V; Ferri F; Riva E; Bambacioni F; Dianzani F
    J Biol Regul Homeost Agents; 1995; 9(2):47-51. PubMed ID: 9127632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-term AZT exposure alters the metabolic capacity of cultured human lymphoblastoid cells.
    Olivero OA; Vazquez IL; Cooch CC; Ming J; Keller E; Yu M; Borojerdi JP; Braun HM; McKee E; Poirier MC
    Toxicol Sci; 2010 May; 115(1):109-17. PubMed ID: 20106944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacodynamic studies (PD) of didanosine (ddI) alone and in combination with azidothymidine (AZT) in human T-cells; a stochastic biochemical approach to antiretroviral nucleoside drug combination in inhibiting HIV-reverse transcriptase (RT).
    Periclou AP; Nandy P; Avramis VI
    In Vivo; 2000; 14(3):377-88. PubMed ID: 10904870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term exposure to zidovudine affects in vitro and in vivo the efficiency of phosphorylation of thymidine kinase.
    Antonelli G; Turriziani O; Verri A; Narciso P; Ferri F; D'Offizi G; Dianzani F
    AIDS Res Hum Retroviruses; 1996 Feb; 12(3):223-8. PubMed ID: 8835200
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cellular metabolism in lymphocytes of a novel thioether-phospholipid-AZT conjugate with anti-HIV-1 activity.
    Kucera GL; Goff CL; Iyer N; Morris-Natschke S; Ishaq KS; Wyrick SD; Fleming RA; Kucera LS
    Antiviral Res; 2001 May; 50(2):129-37. PubMed ID: 11369433
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic mechanisms of drug resistance: drug-induced DNA hypermethylation and drug resistance.
    Nyce J; Leonard S; Canupp D; Schulz S; Wong S
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):2960-4. PubMed ID: 8464912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2',3'-Dideoxycytidine toxicity in cultured human CEM T lymphoblasts: effects of combination with 3'-azido-3'-deoxythymidine and thymidine.
    Törnevik Y; Eriksson S
    Mol Pharmacol; 1990 Aug; 38(2):237-43. PubMed ID: 2166904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ethanol decreases the efficiency of phosphorylation of thymidine kinase in a human T-lymphocytic cell line.
    Prakash O; Tang ZY; Zhou P; Peng X; Kolls J; Shellito JE; Nelson S
    Alcohol Clin Exp Res; 2002 Mar; 26(3):295-302. PubMed ID: 11923581
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships between DNA incorporation, mutant frequency, and loss of heterozygosity at the TK locus in human lymphoblastoid cells exposed to 3'-azido-3'-deoxythymidine.
    Meng Q; Su T; Olivero OA; Poirier MC; Shi X; Ding X; Walker VE
    Toxicol Sci; 2000 Apr; 54(2):322-9. PubMed ID: 10774814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Restoration of the antiviral activity of 3'-azido-3'-deoxythymidine (AZT) against AZT-resistant human immunodeficiency virus by delivery of engineered thymidylate kinase to T cells.
    Lavie A; Su Y; Ghassemi M; Novak RM; Caffrey M; Sekulic N; Monnerjahn C; Konrad M; Cook JL
    J Gen Virol; 2008 Jul; 89(Pt 7):1672-1679. PubMed ID: 18559937
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of in vitro development of drug resistance to azidothymidine in T-lymphocytic leukemia cell lines (Jurkat E6-1/AZT-100) and in pediatric patients with HIV-1 infection.
    Avramis VI; Kwock R; Solorzano MM; Gomperts E
    J Acquir Immune Defic Syndr (1988); 1993 Dec; 6(12):1287-96. PubMed ID: 8254464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a novel (32)P-postlabeling method for the analysis of 3'-azido-3'-deoxythymidine.
    Fang JL; Beland FA
    Cancer Lett; 2000 May; 153(1-2):25-33. PubMed ID: 10779626
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.